We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$92.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$88M
3
BABA icon
Alibaba
BABA
+$73.8M
4
MRK icon
Merck
MRK
+$49.8M
5
MXIM
Maxim Integrated Products
MXIM
+$48.5M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOR
476
DELISTED
MorphoSys AG American Depositary Shares
MOR
$3.16M 0.02%
268,835
– –
PGR icon
477
Progressive
PGR
$124B
$3.16M 0.02%
34,913
-216
-0.6% -$20.6K
DHI icon
478
D.R. Horton
DHI
$40.1B
$3.13M 0.02%
37,333
-2,390
-6% -$220K
WDAY icon
479
Workday
WDAY
$39.6B
$3.11M 0.02%
12,450
-727
-6% -$180K
VMI icon
480
Valmont Industries
VMI
$9.36B
$3.1M 0.02%
13,174
– –
AIG icon
481
American International
AIG
$41.7B
$3.09M 0.02%
56,365
-5,423
-9% -$279K
ZM icon
482
Zoom
ZM
$28.2B
$3.09M 0.02%
11,801
+1,070
+10% +$361K
BC icon
483
Brunswick
BC
$5.14B
$3.07M 0.02%
+32,240
New +$3.21M
PSX icon
484
Phillips 66
PSX
$84.7B
$3.02M 0.02%
43,103
+4,190
+11% +$303K
SCR
485
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
$2.99M 0.02%
+87,448
New +$2.42M
JBGS
486
JBG SMITH
JBGS
$818M
$2.98M 0.02%
100,819
-45,977
-31% -$1.42M
WELL icon
487
Welltower
WELL
$170B
$2.98M 0.02%
36,129
-28,127
-44% -$2.42M
KYNB
488
Kyntra Bio
KYNB
$27.7M
$2.95M 0.02%
11,539
– –
MAR icon
489
Marriott International
MAR
$98.9B
$2.95M 0.02%
19,891
-39,776
-67% -$5.55M
FAST icon
490
Fastenal
FAST
$54.5B
$2.93M 0.02%
113,364
+182
+0.2% +$4.94K
MNST icon
491
Monster Beverage
MNST
$94.6B
$2.92M 0.02%
65,788
-2,898
-4% -$137K
CIT
492
DELISTED
CIT Group Inc.
CIT
$2.91M 0.02%
55,952
– –
DXCM icon
493
DexCom
DXCM
$32.3B
$2.9M 0.02%
21,232
-924
-4% -$117K
EIX icon
494
Edison International
EIX
$28.5B
$2.9M 0.02%
52,338
-2,628
-5% -$151K
STZ icon
495
Constellation Brands
STZ
$22.2B
$2.88M 0.02%
13,649
+549
+4% +$120K
GWW icon
496
W.W. Grainger
GWW
$65.6B
$2.87M 0.02%
7,303
-6,663
-48% -$2.89M
NUVB icon
497
Nuvation Bio
NUVB
$2.2B
$2.85M 0.02%
+287,099
New +$2.6M
AKRO
498
DELISTED
Akero Therapeutics
AKRO
$2.83M 0.02%
126,667
– –
CARR icon
499
Carrier Global
CARR
$51.2B
$2.83M 0.02%
54,617
-2,168
-4% -$117K
AVB icon
500
AvalonBay Communities
AVB
$26.6B
$2.81M 0.02%
12,654
– –
18 19
20
21 22

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.